Clinical Trial Update: A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Early Asymptomatic HIV Infection [NA]

View source ↗

Summary

A completed pilot open-label trial evaluating a four-drug HIV regimen (stavudine, didanosine, nelfinavir, and hydroxyurea) in individuals with early asymptomati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Didanosine (Videx) (didanosine)
• HYDROXYUREA (Hydroxyurea)
• Nelfinavir (nelfinavir)
• Stavudine (Zerit) (stavudine)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: HIV Infections | NA | Status: COMPLETED